Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.26% | 165.19 | 0.7% | $1305.30m | |
| LLY | Eli Lilly & Co. | 0.57% | 331.78 | 1.1% | $1072.82m | |
| ABBV | AbbVie, Inc. | 0.94% | 143.33 | 1.9% | $877.03m | |
| PFE | Pfizer Inc. | -0.47% | 44.25 | 0.9% | $815.29m | |
| BMY | Bristol-Myers Squibb Co. | 0.34% | 71.45 | 1.0% | $767.68m | |
| MRK | Merck & Co., Inc. | 0.01% | 88.40 | 0.7% | $706.05m | |
| AZN | AstraZeneca Plc | -0.54% | 56.73 | 1.0% | $402.73m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.11% | 201.02 | 8.2% | $225.00m | |
| GSK | GSK Plc | -1.01% | 30.40 | 0.3% | $210.45m | |
| NVS | Novartis AG | -1.11% | 77.36 | 0.2% | $209.93m | |
| IDXX | IDEXX Laboratories, Inc. | 0.44% | 350.12 | 3.9% | $189.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.00% | 68.49 | 5.4% | $183.92m | |
| HZNP | Horizon Therapeutics Plc | 1.35% | 67.05 | 5.4% | $182.38m | |
| NVO | Novo Nordisk A/S | 0.63% | 106.04 | 0.1% | $132.75m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.76% | 110.62 | 12.4% | $132.70m |
Company Profile
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.